ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0730

Improving Mental Health Services in Children and Adolescents with Systemic Lupus Erythematosus by Establishing a Mental Health Care Navigator

Colleen Correll, Erika Vaughn, Amanda Schlesinger and Danielle Bullock, University of Minnesota, Minneapolis, MN

Meeting: ACR Convergence 2022

Keywords: Access to care, mental health, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Anxiety and depression are three times more common in children with childhood onset-systemic lupus erythematosus (cSLE) compared to their peers, and both are associated with increased healthcare utilization, poor medication adherence and school performance, worse outcomes and quality of life, and difficulty with transition to adult care. Lack of sufficient services for mental health (MH) care in cSLE is well-recognized in pediatric rheumatology. Lack of adequate resources is the most commonly reported barrier to screening for MH diseases and accessing care. We received grant funding to create a new position called a Mental Health Care Navigator (MHCN) to improve our MH screenings, referrals, and treatment for patients with cSLE who are seen at our Pediatric Rheumatology Clinic. Here, we present our new program and preliminary findings.

Methods: We hired an experienced clinical social worker for the MHCN role. Patients with cSLE are screened for depression and anxiety. Patients 12+ complete the Patient Health Questionnaire for Adolescents (PHQ-A) and the General Anxiety Disorder-7 (GAD-7); patients ages 8-11 complete the Center for Epidemiological Studies Depression Scale for Children (CES-DC) and Screen for Child Anxiety Related Disorders (SCARED) every 6 months at their routine rheumatology appointment. Depending on screening results, the MHCN facilities referrals to community MH providers or specialists at the University if needed (Figure 1). We are collecting outcome metrics including rates of MH screening, meeting with the MHCN, referrals and no-shows. Next steps include collecting hospitalization rates, medication adherence, and patient/family and provider perception of the MHCN program. We are also conducting four MH Training Sessions for pediatric rheumatology clinic staff.

Results: Since the initiation of the program 6 months ago, the MHCN has met with 42/61 (69%) patients with cSLE in 83 encounters. We have screened 29/61 (48%) for depression and anxiety, and we have referred 7/29 (24%) to MH services after screening; 11/29 (38%) had MH services prior to screening. The MHCN is also developing culturally competent patient educational materials, coordinating community support groups, and helping patients gain access to advocacy foundations. We have completed 1 of 4 MH training sessions for pediatric rheumatology providers.

Conclusion: cSLE is a complex disease and is associated with high rates of MH diagnoses . Despite this, patients face many barriers to accessing MH services. We created a new program using a MHCN to help patients overcome these barriers and to educate rheumatology providers. In the short time since the start of the program, the MCHN has met with the majority of our patients with cSLE, created a standardized MH screening program, and is developing a variety of resources for patients and families. We anticipate that our outcome metrics will demonstrate that this model is effective. This preliminary program can provide a model for other centers seeking to improve MH service utilization. With additional funding, we plan to expand the program to assist other pediatric rheumatology patients with complex disease and MH care needs.

Supporting image 1

Figure 1. Process for mental health screening and referrals.


Disclosures: C. Correll, None; E. Vaughn, None; A. Schlesinger, None; D. Bullock, None.

To cite this abstract in AMA style:

Correll C, Vaughn E, Schlesinger A, Bullock D. Improving Mental Health Services in Children and Adolescents with Systemic Lupus Erythematosus by Establishing a Mental Health Care Navigator [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/improving-mental-health-services-in-children-and-adolescents-with-systemic-lupus-erythematosus-by-establishing-a-mental-health-care-navigator/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improving-mental-health-services-in-children-and-adolescents-with-systemic-lupus-erythematosus-by-establishing-a-mental-health-care-navigator/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology